I was drafted out of college in 1961, promoted to grade of E5. Liked the job but not the
money so applied for and completed OCS. Got married and wanted out but they sent
me to Hawaii. Loved the Army. Then they sent me to Vietnam. Twice. And Thailand for
another year. Since I had 11 years in when the war ended I finished the 20 and retired
to the family farm to raise beef cattle and purebred bird dogs. Made some money on
the Weimaraners, the cows not so much. Price farm machinery and repair thereof and
you will see why the family farm disappeared. Always undercapitalized, heavily taxed,
over-regulated (EPA, INS, IRS, USDA, etc.). I'm now retired again, disabled, and play
the market just to keep my savings from being devoured by inflation.
I consider myself a 50/50 technical/fundamental trader and investor. I have carved a niche in analyzing small cap biotechnology companies and analyzing trial data, design and company structure. I mainly trade catalyst-driven stocks with good cash positions and promising therapies. Overall, my specialty is trial data. Over the past 6 years of research and investing, I have learned of the many ways to make money trading these extremely volatile and speculative biotech plays, particularly by making the best assumptions and educated guesses possible on trial data and company structure and management. I play the FDA calendar and pick the best companies possible for run-ups to data. I also do research for Stockmatusow.com, and collaborate with Scott Matusow and Kyle Dennis on articles and trade calls.
Founder and Managing Principal of TBJ Investments, LLC. Currently Investor at Buzzient, Inc. Previously CEO at Buzzient, BionTTech and EBA Systems. Former Associate at Mohr, Davidow Ventures. Investing in early stage software/web/mobile,university commercializations and spin outs. Developing interest in energy and natural resources.